China Immunotech (beijing) Biotechnology Co., Ltd.

This early-stage trial tested a new cell therapy called YTS109 in 7 people with a severe type of autoimmune anemia that did not get better after at least 3 other treatments. The goal was to see if the therapy is safe and can help control the disease. Researchers used special immu…